Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Llibre

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
HIV Medicine|January 29, 2019
Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohortJ M Llibre, A Montoliu, J M Miró, et al.
HIV Medicine|January 29, 2019
Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfectionJ J Malin, C Boesecke, C Schwarze-Zander, et al.
HIV Clinical Trials|July 13, 2004
Health-related quality of life in HIV-infected naive patients treated with nelfinavir or nevirapine associated with ZDV/3TC (the COMBINE-QoL substudy)A Casado, X Badia, E Consiglio, et al.
HIV Medicine|November 28, 2015
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapyA Winston, W Stöhr, A Antinori, et al.
Open Forum Infectious Diseases|March 3, 2022
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)D Podzamczer, R Micán, J Tiraboschi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2016
Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus CoinfectionDavid Nicolás, Anna Esteve, Anna Cuadros, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
HIV Medicine|January 29, 2019
Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohortJ M Llibre, A Montoliu, J M Miró, et al.
HIV Medicine|January 29, 2019
Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfectionJ J Malin, C Boesecke, C Schwarze-Zander, et al.
HIV Clinical Trials|July 13, 2004
Health-related quality of life in HIV-infected naive patients treated with nelfinavir or nevirapine associated with ZDV/3TC (the COMBINE-QoL substudy)A Casado, X Badia, E Consiglio, et al.
HIV Medicine|November 28, 2015
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapyA Winston, W Stöhr, A Antinori, et al.
Open Forum Infectious Diseases|March 3, 2022
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)D Podzamczer, R Micán, J Tiraboschi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2016
Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus CoinfectionDavid Nicolás, Anna Esteve, Anna Cuadros, et al.
Pageof 6